BioVaxys Technology is pleased to announce that interim results from its ongoing preclinical animal study of BXV-0320, its SARS-CoV-2 vaccine candidate, show a good emerging tolerability profile with no observed side effects or noteworthy clinical observations. Five weeks post-administration of BVX-0320 in the murine animal model, no toxicities [...]
BioVaxys Technology Corp. is pleased to announce the completion of its formerly announced acquisition of all of the securities BioVaxys Inc. The Transaction was determined to be a "fundamental change" pursuant to the policies of the Canadian Securities Exchange and the Company has re-classified itself from being a resource issuer to an industrial [...]
Lions Bay Mining is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement. Under the final tranche of the Private Placement, the Company issued 2,954,582 units at a price of $0.22 per Unit for total gross proceeds of approximately $650,008.00, and together with the first [...]
Lions Bay Mining Corp. is pleased to announce that, following the execution of a Share Exchange Agreement with BioVaxys, the Company has executed a USD$180,000 secured lending facility with BioVaxys, the proceeds of which will be used primarily for BioVaxys' preclinical studies of BVX-0320, a novel vaccine candidate for prevention of Covid-19 [...]
Lions Bay Mining is pleased to announce that it has executed a Share Exchange Agreement with BioVaxys Inc., a clinical-stage immunotherapeutics company developing vaccine platforms for SARS-CoV-2 and various cancers. Under the terms of transaction, the Company will acquire all of the issued and outstanding shares of common stock of BioVaxys. Terms [...]
Lions Bay Mining Corp. is pleased to announce that it has been informed that BioVaxys LLC is in the process of preparing to launch a preclinical study of its proprietary vaccine for SARS-CoV-2, the virus that causes Covid-19. Lions Bay recently announced entering into a non-binding letter of intent dated April 17th, 2020 to acquire BioVaxys, a [...]
Lions Bay Mining has announced a two for one stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive one additional shares for each share held on such date. The shares will begin trading on a split basis on April 28, 2020. Upon completion of the split, there [...]
Lions Bay Mining Corp. the "Company" or "Lions Bay") confirms the Record Date of April 29th, 2020 for the upcoming two-for-one stock split of the Company's common shares. Shareholders as of the Record Date will receive two new common shares for every one common share held . The Company will use the "push-out" method to issue the additional common [...]
Lions Bay Mining Corp. is pleased to announce it has entered into a non-binding letter of intent dated April 17th, 2020 to acquire BioVaxys LLC a private Delaware corporation. BioVaxys is a clinical stage biopharma company developing immunotherapeutic vaccines for life-threatening viral infections and various cancers. BioVaxys's vaccine technology [...]
Lions Bay Mining Corp. announces that it intends to subdivide its share capital on a 1 old share for 2 new shares basis , subject to receipt of approval by the Canadian Securities Exchange . In the event the Stock Split is completed, the outstanding common shares of the Company will increase from 10,727,428 to 21,454,856. The Company will [...]
Lions Bay Mining Corp. announces that it has terminated the property purchase agreement entered into with Golden Predator Mining Corp. for the sale of certain of its mineral claims located in the Yukon Territory. Under the terms of the property purchase agreement, Golden Predator was required to make cash payments and issue Golden Predator common [...]
Lions Bay Mining Corp. is pleased to announce that, effective at the open of market today, its common shares commenced trading on the Canadian Securities Exchange under the symbol LBM. In addition, the Company announces it has closed a non-brokered private placement offering of 5,000,000 units at a price of $0.10 per Unit for gross proceeds of [...]
